Top

Published in:

Open Access 01-05-2021 | Heart Failure

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification

Authors: Gavin A. Lewis, Keith Pearce, Simon G. Williams, Erik B. Schelbert, Anita Macnab, Christopher A. Miller

Published in: Heart Failure Reviews | Issue 3/2021

Abstract

Heart failure with preserved ejection fraction (HFpEF) does not exist as a singular clinical or pathological entity but as a syndrome encompassing a wide range of clinical and biological phenotypes. There is an urgent need to progress from the unsuccessful ‘one-size-fits-all’ approach to more precise disease classification, in order to develop targeted therapies, personalise risk stratification and guide future research. In this regard, this review discusses the current and emerging roles of cardiovascular imaging for the diagnosis of HFpEF, for distilling HFpEF into distinct disease entities according to underlying pathobiology and for risk stratification.

Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: A multiorgan roadmap. Circulation 134(1):73–90. https://doi.org/10.1161/CIRCULATIONAHA.116.021884CrossRefPubMedPubMedCentral

Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA (2017) Biological phenotypes of heart failure with preserved ejection fraction. J Am Coll Cardiol 70(17):2186–2200. https://doi.org/10.1016/j.jacc.2017.09.006CrossRefPubMed

Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA (2017) Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 136(1):6–19. https://doi.org/10.1161/CIRCULATIONAHA.116.026807CrossRefPubMedPubMedCentral

Anand IS, Claggett B, Liu J, Shah AM, Rector TS, Shah SJ, Desai AS, O’Meara E, Fleg JL, Pfeffer MA, Pitt B, Solomon SD (2017) Interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT Trial. JACC Heart Fail 5(4):241–252. https://doi.org/10.1016/j.jchf.2016.11.015CrossRefPubMed

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314. https://doi.org/10.1016/j.echo.2016.01.011CrossRefPubMed

Kosmala W, Rojek A, Przewlocka-Kosmala M, Mysiak A, Karolko B, Marwick TH (2016) Contributions of nondiastolic factors to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 67(6):659–670. https://doi.org/10.1016/j.jacc.2015.10.096CrossRefPubMed

Peverill RE (2015) “Left ventricular filling pressure(s)” - ambiguous and misleading terminology, best abandoned. Int J Cardiol 191:110–113. https://doi.org/10.1016/j.ijcard.2015.04.254CrossRefPubMed

Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 30(1):8–18CrossRefPubMed

Mirsky I (1984) Assessment of diastolic function: Suggested methods and future considerations. Circulation 69(4):836–841CrossRefPubMed

10.

Brutsaert DL, Rademakers FE, Sys SU (1984) Triple control of relaxation: Implications in cardiac disease. Circulation 69(1):190–196CrossRefPubMed

11.

Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF (2007) Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 115(11):1376–1383. https://doi.org/10.1161/CIRCULATIONAHA.106.662882CrossRefPubMed

12.

Yotti R, Bermejo J, Benito Y, Antoranz JC, Desco MM, Rodriguez-Perez D, Cortina C, Mombiela T, Barrio A, Elizaga J, Fernandez-Aviles F (2011) Noninvasive estimation of the rate of relaxation by the analysis of intraventricular pressure gradients. Circ Cardiovasc Imaging 4(2):94–104. https://doi.org/10.1161/CIRCIMAGING.110.960369CrossRefPubMed

13.

Garcia MJ, Palac RT, Malenka DJ, Terrell P, Plehn JF (1999) Color M-mode Doppler flow propagation velocity is a relatively preload-independent index of left ventricular filling. J Am Soc Echocardiogr 12(2):129–137. https://doi.org/10.1016/s0894-7317(99)70125-2CrossRefPubMed

14.

Dong SJ, Hees PS, Siu CO, Weiss JL, Shapiro EP (2001) MRI assessment of LV relaxation by untwisting rate: A new isovolumic phase measure of tau. Am J Physiol Heart Circ Physiol 281(5):H2002-2009. https://doi.org/10.1152/ajpheart.2001.281.5.H2002CrossRefPubMed

15.

Notomi Y, Popovic ZB, Yamada H, Wallick DW, Martin MG, Oryszak SJ, Shiota T, Greenberg NL, Thomas JD (2008) Ventricular untwisting: A temporal link between left ventricular relaxation and suction. Am J Physiol Heart Circ Physiol 294(1):H505-513. https://doi.org/10.1152/ajpheart.00975.2007CrossRefPubMed

16.

Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County. Minnesota Circulation 115(15):1982–1990. https://doi.org/10.1161/CIRCULATIONAHA.106.659763CrossRefPubMed

17.

Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ (2014) Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 7(2):288–299. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000854CrossRefPubMed

18.

Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous doppler-catheterization study. Circulation 102(15):1788–1794CrossRefPubMed

19.

Yamamoto K, Nishimura RA, Redfield MM (1996) Assessment of mean left atrial pressure from the left ventricular pressure tracing in patients with cardiomyopathies. Am J Cardiol 78(1):107–110. https://doi.org/10.1016/s0002-9149(96)00238-xCrossRefPubMed

20.

Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr, Tajik AJ (1996) Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: A simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 28(5):1226–1233. https://doi.org/10.1016/S0735-1097(96)00315-4CrossRefPubMed

21.

Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE, Investigators IP (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124(23):2491–2501. https://doi.org/10.1161/CIRCULATIONAHA.110.011031CrossRefPubMed

22.

Shah AM, Shah SJ, Anand IS, Sweitzer NK, O’Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, Investigators T (2014) Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail 7(1):104–115. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000887CrossRefPubMed

23.

Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM (2010) Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3(5):588–595. https://doi.org/10.1161/CIRCHEARTFAILURE.109.930701CrossRefPubMedPubMedCentral

24.

Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO, Huang CC, Deo RC (2015) Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 131(3):269–279. https://doi.org/10.1161/CIRCULATIONAHA.114.010637CrossRefPubMed

25.

Cuspidi C, Rescaldani M, Sala C (2013) Prevalence of echocardiographic left-atrial enlargement in hypertension: A systematic review of recent clinical studies. Am J Hypertens 26(4):456–464. https://doi.org/10.1093/ajh/hpt001CrossRefPubMed

26.

Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA (2017) Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: A simultaneous invasive-echocardiographic study. Circulation 135(9):825–838. https://doi.org/10.1161/CIRCULATIONAHA.116.024822CrossRefPubMed

27.

Talreja DR, Nishimura RA, Oh JK (2007) Estimation of left ventricular filling pressure with exercise by Doppler echocardiography in patients with normal systolic function: A simultaneous echocardiographic-cardiac catheterization study. J Am Soc Echocardiogr 20(5):477–479. https://doi.org/10.1016/j.echo.2006.10.005CrossRefPubMed

28.

Telles F, Nanayakkara S, Evans S, Patel HC, Mariani JA, Vizi D, William J, Marwick TH, Kaye DM (2019) Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction. Eur J Heart Fail. https://doi.org/10.1002/ejhf.1399CrossRefPubMed

29.

Kanagala P, Cheng ASH, Singh A, McAdam J, Marsh AM, Arnold JR, Squire IB, Ng LL, McCann GP (2018) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials. J Cardiovasc Magn Reson 20(1):4. https://doi.org/10.1186/s12968-017-0424-9CrossRefPubMedPubMedCentral

30.

Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Dungen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP, Investigators P-H, Committees, (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609–1620. https://doi.org/10.1056/NEJMoa1908655CrossRefPubMed

31.

Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111(6):774–781. https://doi.org/10.1161/01.CIR.0000155257.33485.6DCrossRefPubMed

32.

Zile MR, Baicu CF, Ikonomidis JS, Stroud RE, Nietert PJ, Bradshaw AD, Slater R, Palmer BM, Van Buren P, Meyer M, Redfield MM, Bull DA, Granzier HL, LeWinter MM (2015) Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation 131(14):1247–1259. https://doi.org/10.1161/CIRCULATIONAHA.114.013215CrossRefPubMedPubMedCentral

33.

Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6(3):373–383. https://doi.org/10.1161/CIRCIMAGING.112.000192CrossRefPubMed

34.

Schelbert EB, Fridman Y, Wong TC, Abu Daya H, Piehler KM, Kadakkal A, Miller CA, Ugander M, Maanja M, Kellman P, Shah DJ, Abebe KZ, Simon MA, Quarta G, Senni M, Butler J, Diez J, Redfield MM, Gheorghiade M (2017) Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: Association with baseline disease severity and subsequent outcome. JAMA Cardiol 2(9):995–1006. https://doi.org/10.1001/jamacardio.2017.2511CrossRefPubMedPubMedCentral

35.

Mordi IR, Singh S, Rudd A, Srinivasan J, Frenneaux M, Tzemos N, Dawson DK (2018) Comprehensive echocardiographic and cardiac magnetic resonance evaluation differentiates among heart failure with preserved ejection fraction patients, hypertensive patients, and healthy control subjects. JACC Cardiovasc Imaging 11(4):577–585. https://doi.org/10.1016/j.jcmg.2017.05.022CrossRefPubMed

36.

Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lucke C, Gutberlet M, Linke A, Schuler G, Lurz P (2016) Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 67(15):1815–1825. https://doi.org/10.1016/j.jacc.2016.02.018CrossRefPubMed

37.

Hunter WG, Kelly JP, McGarrah RW, 3rd, Khouri MG, Craig D, Haynes C, Ilkayeva O, Stevens RD, Bain JR, Muehlbauer MJ, Newgard CB, Felker GM, Hernandez AF, Velazquez EJ, Kraus WE, Shah SH (2016) Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure. J Am Heart Assoc 5 (8). https://doi.org/10.1161/JAHA.115.003190

38.

Sabbah HN, Sharov VG, Lesch M, Goldstein S (1995) Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 147(1–2):29–34CrossRefPubMed

39.

Hudsmith LE, Neubauer S (2009) Magnetic resonance spectroscopy in myocardial disease. JACC Cardiovasc Imaging 2(1):87–96. https://doi.org/10.1016/j.jcmg.2008.08.005CrossRefPubMed

40.

Phan TT, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L, Dwivedi G, Patel K, Steendijk P, Ashrafian H, Henning A, Frenneaux M (2009) Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol 54(5):402–409. https://doi.org/10.1016/j.jacc.2009.05.012CrossRefPubMed

41.

Mahmod M, Pal N, Rayner J, Holloway C, Raman B, Dass S, Levelt E, Ariga R, Ferreira V, Banerjee R, Schneider JE, Rodgers C, Francis JM, Karamitsos TD, Frenneaux M, Ashrafian H, Neubauer S, Rider O (2018) The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: A cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 20(1):88. https://doi.org/10.1186/s12968-018-0511-6CrossRefPubMedPubMedCentral

42.

Lewis GA, Schelbert EB, Naish JH, Bedson E, Dodd S, Eccleson H, Clayton D, Jimenez BD, McDonagh T, Williams SG, Cooper A, Cunnington C, Ahmed FZ, Viswesvaraiah R, Russell S, Neubauer S, Williamson PR, Miller CA (2019) Pirfenidone in heart failure with preserved ejection fraction-rationale and design of the PIROUETTE Trial. Cardiovasc Drugs Ther 33(4):461–470. https://doi.org/10.1007/s10557-019-06876-yCrossRefPubMedPubMedCentral

43.

van Empel VP, Mariani J, Borlaug BA, Kaye DM (2014) Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction. J Am Heart Assoc 3(6):e001293. https://doi.org/10.1161/JAHA.114.001293CrossRefPubMedPubMedCentral

44.

Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271. https://doi.org/10.1016/j.jacc.2013.02.092CrossRefPubMed

45.

Srivaratharajah K, Coutinho T, deKemp R, Liu P, Haddad H, Stadnick E, Davies RA, Chih S, Dwivedi G, Guo A, Wells GA, Bernick J, Beanlands R, Mielniczuk LM (2016) Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction. Circ Heart Fail 9 (7). https://doi.org/10.1161/CIRCHEARTFAILURE.115.002562

46.

Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Kimura K, Umemura S (2016) Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 5 (2). https://doi.org/10.1161/JAHA.115.002649

47.

Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, Hainer J, Bibbo CF, Dorbala S, Blankstein R, Di Carli MF (2018) Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 39(10):840–849. https://doi.org/10.1093/eurheartj/ehx721CrossRefPubMed

48.

Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, Beussink-Nelson L, Fermer ML, Broberg MA, Gan LM, Lund LH (2018) Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 39(37):3439–3450. https://doi.org/10.1093/eurheartj/ehy531CrossRefPubMedPubMedCentral

49.

Olsen RH, Pedersen LR, Snoer M, Christensen TE, Ghotbi AA, Hasbak P, Kjaer A, Haugaard SB, Prescott E (2016) Coronary flow velocity reserve by echocardiography: Feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease. Cardiovasc Ultrasound 14(1):22. https://doi.org/10.1186/s12947-016-0066-3CrossRefPubMedPubMedCentral

50.

Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM (2009) Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 54(5):410–418. https://doi.org/10.1016/j.jacc.2009.05.013CrossRefPubMedPubMedCentral

51.

Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA (2012) Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol 59(5):442–451. https://doi.org/10.1016/j.jacc.2011.09.062CrossRefPubMed

52.

Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD, Investigators P (2014) Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 63(5):447–456. https://doi.org/10.1016/j.jacc.2013.09.052CrossRefPubMed

53.

Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Liu L, Pitt B, Pfeffer MA, Solomon SD (2015) Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132(5):402–414. https://doi.org/10.1161/CIRCULATIONAHA.115.015884CrossRefPubMedPubMedCentral

54.

Tan YT, Wenzelburger F, Lee E, Heatlie G, Leyva F, Patel K, Frenneaux M, Sanderson JE (2009) The pathophysiology of heart failure with normal ejection fraction: Exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 54(1):36–46. https://doi.org/10.1016/j.jacc.2009.03.037CrossRefPubMed

55.

Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29(10):1283–1289. https://doi.org/10.1093/eurheartj/ehn141CrossRefPubMed

56.

Bianco CM, Farjo PD, Ghaffar YA, Sengupta PP (2020) Myocardial Mechanics in patients with normal LVEF and diastolic dysfunction. JACC Cardiovasc Imaging 13(1 Pt 2):258–271. https://doi.org/10.1016/j.jcmg.2018.12.035CrossRefPubMed

57.

Freed BH, Daruwalla V, Cheng JY, Aguilar FG, Beussink L, Choi A, Klein DA, Dixon D, Baldridge A, Rasmussen-Torvik LJ, Maganti K, Shah SJ (2016) Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain. Circ Cardiovasc Imaging 9 (3). https://doi.org/10.1161/CIRCIMAGING.115.003754

58.

Kurt M, Wang J, Torre-Amione G, Nagueh SF (2009) Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging 2(1):10–15. https://doi.org/10.1161/CIRCIMAGING.108.813071CrossRefPubMed

59.

Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, Tacchini D, Geyer A, Curci V, Di Tommaso C, Lisi G, Maccherini M, Chiavarelli M, Massetti M, Tanganelli P, Mondillo S (2013) Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 111(4):595–601. https://doi.org/10.1016/j.amjcard.2012.10.049CrossRefPubMed

60.

Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, Herrington DM, Link KM, Little WC (2001) Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38(3):796–802CrossRefPubMed

61.

Weber T, Wassertheurer S, O’Rourke MF, Haiden A, Zweiker R, Rammer M, Hametner B, Eber B (2013) Pulsatile hemodynamics in patients with exertional dyspnea: Potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction. J Am Coll Cardiol 61(18):1874–1883. https://doi.org/10.1016/j.jacc.2013.02.013CrossRefPubMed

62.

Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric oxide and the regulation of large artery stiffness: From physiology to pharmacology. Hypertension 44(2):112–116. https://doi.org/10.1161/01.HYP.0000138068.03893.40CrossRefPubMed

63.

DeVallance E, Fournier S, Lemaster K, Moore C, Asano S, Bonner D, Donley D, Olfert IM, Chantler PD (2016) The effects of resistance exercise training on arterial stiffness in metabolic syndrome. Eur J Appl Physiol 116(5):899–910. https://doi.org/10.1007/s00421-016-3348-4CrossRefPubMedPubMedCentral

64.

Kitzman DW, Herrington DM, Brubaker PH, Moore JB, Eggebeen J, Haykowsky MJ (2013) Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction. Hypertension 61(1):112–119. https://doi.org/10.1161/HYPERTENSIONAHA.111.00163CrossRefPubMed

65.

Kitzman DW, Hundley WG, Brubaker PH, Morgan TM, Moore JB, Stewart KP, Little WC (2010) A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: Effects on exercise tolerance and arterial distensibility. Circ Heart Fail 3(4):477–485. https://doi.org/10.1161/CIRCHEARTFAILURE.109.898916CrossRefPubMedPubMedCentral

66.

el Ibrahim SH, Johnson KR, Miller AB, Shaffer JM, White RD (2010) Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: Comparison of techniques. J Cardiovasc Magn Reson 12:26. https://doi.org/10.1186/1532-429X-12-26CrossRefPubMedCentral

67.

Chirinos JA (2017) Deep Phenotyping of systemic arterial hemodynamics in HFpEF (part 1): Physiologic and technical considerations. J Cardiovasc Transl Res 10(3):245–259. https://doi.org/10.1007/s12265-017-9735-3CrossRefPubMedPubMedCentral

68.

Reddy YNV, Andersen MJ, Obokata M, Koepp KE, Kane GC, Melenovsky V, Olson TP, Borlaug BA (2017) Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 70(2):136–148. https://doi.org/10.1016/j.jacc.2017.05.029CrossRefPubMedPubMedCentral

69.

Chirinos JA, Bhattacharya P, Kumar A, Proto E, Konda P, Segers P, Akers SR, Townsend RR, Zamani P (2019) Impact of diabetes mellitus on ventricular structure, arterial stiffness, and pulsatile hemodynamics in heart failure with preserved ejection fraction. J Am Heart Assoc 8(4):e011457. https://doi.org/10.1161/JAHA.118.011457CrossRefPubMedPubMedCentral

70.

Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM (2010) Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 56(11):855–863. https://doi.org/10.1016/j.jacc.2010.04.040CrossRefPubMed

71.

Tsao CW, Lyass A, Larson MG, Levy D, Hamburg NM, Vita JA, Benjamin EJ, Mitchell GF, Vasan RS (2015) Relation of Central Arterial Stiffness to Incident Heart Failure in the Community. J Am Heart Assoc 4 (11). https://doi.org/10.1161/JAHA.115.002189

72.

Upadhya B, Hundley WG, Brubaker PH, Morgan TM, Stewart KP, Kitzman DW (2017) Effect of spironolactone on exercise tolerance and arterial function in older adults with heart failure with preserved ejection fraction. J Am Geriatr Soc 65(11):2374–2382. https://doi.org/10.1111/jgs.14940CrossRefPubMedPubMedCentral

73.

Jumean MF, Konstam MA (2015) Heart failure with preserved ejection fraction: What is in a name? Cardiol Rev 23(4):161–167. https://doi.org/10.1097/CRD.0000000000000057CrossRefPubMed

74.

Solomon SD, Rizkala AR, Gong J, Wang W, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Shi VC, Lefkowitz MP, McMurray JJV (2017) Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: Rationale and design of the PARAGON-HF trial. JACC Heart Fail 5(7):471–482. https://doi.org/10.1016/j.jchf.2017.04.013CrossRefPubMed

75.

Anker SD, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Brueckmann M, Zannad F, Packer M, Committees EM-PT, Investigators, (2019) Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: Rationale for and design of the EMPEROR-Preserved Trial. Eur J Heart Fail 21(10):1279–1287. https://doi.org/10.1002/ejhf.1596CrossRefPubMed

76.

Gottdiener JS, Fohner AE (2020) Risk prediction in heart failure: New methods. Old Problems JACC Heart Fail 8(1):22–24. https://doi.org/10.1016/j.jchf.2019.08.015CrossRefPubMed

77.

Garcia MJ, Ares MA, Asher C, Rodriguez L, Vandervoort P, Thomas JD (1997) An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 29(2):448–454. https://doi.org/10.1016/s0735-1097(96)00496-2CrossRefPubMed

78.

Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30(6):1527–1533CrossRefPubMed

79.

Firstenberg MS, Levine BD, Garcia MJ, Greenberg NL, Cardon L, Morehead AJ, Zuckerman J, Thomas JD (2000) Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol 36(5):1664–1669. https://doi.org/10.1016/s0735-1097(00)00909-8CrossRefPubMed

80.

Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA (1998) Doppler estimation of left ventricular filling pressure in sinus tachycardia A new application of tissue doppler imaging. Circulation 98(16):1644–1650. https://doi.org/10.1161/01.cir.98.16.1644CrossRefPubMed

81.

Oki T, Tabata T, Yamada H, Wakatsuki T, Shinohara H, Nishikado A, Iuchi A, Fukuda N, Ito S (1997) Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 79(7):921–928. https://doi.org/10.1016/s0002-9149(97)00015-5CrossRefPubMed

82.

Schwammenthal E, Popescu BA, Popescu AC, Di Segni E, Kaplinsky E, Rabinowitz B, Guetta V, Rath S, Feinberg MS (2000) Noninvasive assessment of left ventricular end-diastolic pressure by the response of the transmitral a-wave velocity to a standardized Valsalva maneuver. Am J Cardiol 86(2):169–174. https://doi.org/10.1016/s0002-9149(00)00855-9CrossRefPubMed

83.

Appleton CP, Hatle LK, Popp RL (1988) Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12(2):426–440. https://doi.org/10.1016/0735-1097(88)90416-0CrossRefPubMed

84.

Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: A comparative Doppler-conductance catheterization study. Circulation 116(6):637–647. https://doi.org/10.1161/CIRCULATIONAHA.106.661983CrossRefPubMed

85.

Garcia MJ, Firstenberg MS, Greenberg NL, Smedira N, Rodriguez L, Prior D, Thomas JD (2001) Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans. Am J Physiol Heart Circ Physiol 280(2):H554-561. https://doi.org/10.1152/ajpheart.2001.280.2.H554CrossRefPubMed

86.

Kim YJ, Sohn DW (2000) Mitral annulus velocity in the estimation of left ventricular filling pressure: Prospective study in 200 patients. J Am Soc Echocardiogr 13(11):980–985. https://doi.org/10.1067/mje.2000.107156CrossRefPubMed

87.

Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30(2):474–480CrossRefPubMed

88.

Sohn DW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, Kim HC (1999) Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 12(11):927–931CrossRefPubMed

89.

Kasner M, Sinning D, Burkhoff D, Tschope C (2015) Diastolic pressure-volume quotient (DPVQ) as a novel echocardiographic index for estimation of LV stiffness in HFpEF. Clin Res Cardiol 104(11):955–963. https://doi.org/10.1007/s00392-015-0863-yCrossRefPubMed

90.

Bouchard JL, Aurigemma GP, Hill JC, Ennis CA, Tighe DA (2008) Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function. Am J Cardiol 101(11):1673–1676. https://doi.org/10.1016/j.amjcard.2008.01.054CrossRefPubMed

91.

McQuillan BM, Picard MH, Leavitt M, Weyman AE (2001) Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 104(23):2797–2802. https://doi.org/10.1161/hc4801.100076CrossRefPubMed

92.

Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, HumbertNaeije MR, Pepke-Zaba J, Task F (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243–2278. https://doi.org/10.1016/j.ehj.2004.09.014CrossRefPubMed

93.

Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90(12):1284–1289. https://doi.org/10.1016/s0002-9149(02)02864-3CrossRefPubMed

94.

Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing G, American Society of Echocardiography’s G, Standards E European Association of C (2005) Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463. https://doi.org/10.1016/j.echo.2005.10.005CrossRefPubMed

95.

Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107–133. https://doi.org/10.1016/j.echo.2008.11.023CrossRefPubMed

96.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (1):1–39 e14. https://doi.org/10.1016/j.echo.2014.10.003

97.

Raff GL, Glantz SA (1981) Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res 48(6):813–824. https://doi.org/10.1161/01.res.48.6.813CrossRefPubMed

98.

Weiss JL, Frederiksen JW, Weisfeldt ML (1976) Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58(3):751–760. https://doi.org/10.1172/JCI108522CrossRefPubMedPubMedCentral

Title: The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification
Authors: Gavin A. Lewis
Keith Pearce
Simon G. Williams
Erik B. Schelbert
Anita Macnab
Christopher A. Miller
Publication date: 01-05-2021
Publisher: Springer US
Keyword: Heart Failure
Published in: Heart Failure Reviews / Issue 3/2021
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-020-10047-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Cardiogenic shock and acute kidney injury: the rule rather than the exception

The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock

Response to letter to Editor by: Josef Finsterer

Cost-effectiveness analysis of mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation: a systematic review

Machine learning and statistical methods for predicting mortality in heart failure

The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page